Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India

Published: Wednesday, September 23, 2009
Last Updated: Wednesday, September 23, 2009
Bookmark and Share
Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.

“Bioscreen is a leading distributor in India. They will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we continue to expand throughout Asia, Bioscreen will help us further broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them, Bioscreen will provide them with industry-leading Labcyte acoustic technology for compound management, high-throughput and secondary screening. Bioscreen will give our new customers in India immediate support and interaction.

“Bioscreen will also introduce us to new users in the growing genomics market. We feel that with the Labcyte platforms, Bioscreen can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free.”

“We are extremely pleased to be the Labcyte partner in India. It is a great recognition of our distributor capabilities across the entire country of India. Labcyte products will allow us to provide our customers with state-of-the-art platform technology so that they can excel in their efforts,” said Mr. S. Radha Krishnan, Managing Director of Bioscreen Instruments. “We see a great potential market for low-volume liquid handlers in India. We believe that the miniaturization capabilities provided by Labcyte technology will be especially useful for the growing genomics markets, especially for gene expression, SNP analysis and RNAi.”

“As the market moves to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential,” said Dr. Nick Samaras, Labcyte Managing Director, Asia-Pacific. “In particular, our Echo® liquid handler provides superior results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Labcyte Receives $1 Million NCI Award
The award will be used to create an innovative process to detect cancer-related proteins in samples, with initial work in breast cancer detection.
Friday, November 22, 2013
Labcyte Announces Collaboration with AstraZeneca
Companies collaborate to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications.
Wednesday, September 25, 2013
Moving Liquids with Sound Helps Identify Drug Candidates that Traditional Lab Techniques Miss
A paper published by the journal PLOS ONE, May 1, 2013, demonstrates that the technique used to transfer compound solutions does indeed matter.
Friday, May 03, 2013
Labcyte Inc. Closes $5.3 Million Financing
Privately-held company with products that advance acoustic liquid handling closes a Series D financing.
Thursday, January 10, 2013
Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments
Collaboration expected to further the development of personalized medicine in cancer treatment.
Tuesday, January 08, 2013
Cancer Research Technology Selects the Labcyte Access™ Laboratory Workstation
Labcyte Access workstation to automate the production of assay-ready plates used in CRT's high-throughput cell based screening program
Monday, June 25, 2012
Labcyte Secures NIH Funding
The award of $196K from the National Cancer Institute will fund a collaborative cancer biomarker validation program with the Canary Center of Stanford University.
Wednesday, November 09, 2011
Labcyte Awarded 1st Patent in China
Labcyte has announced the grant of its first patent in China. Patent CN 101035681B describes how acoustic energy is used to assess the characteristics of any fluid in real time to optimize its transfer.
Thursday, September 30, 2010
Labcyte Awarded 40th US Patent
Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid.
Wednesday, August 25, 2010
Labcyte Awarded Second Japanese Patent
Patent covers the design for acoustics used for cell sorting and transfer.
Wednesday, August 19, 2009
Labcyte Echo Acoustic Liquid Handler an Essential Component of Pharmaceutical High-Throughput Screening
Recent issue of JBS emphasizes the importance of acoustic liquid handling in drug discovery.
Friday, August 07, 2009
Labcyte Awarded U. S. Patent Describing the Acoustic Transfer of Droplets into Small Openings Moving liquids with Sound™
The patent describes the acoustic transfer of fluid droplets into openings less than 300 microns in diameter.
Thursday, November 06, 2008
Portrait™ 630 Reagent Multi-Spotter Wins Technology Prize at MipTec 10th Anniversary Conference
The European Laboratory Robotics Interest Group has selected the Labcyte Portrait 630 reagent multi-spotter as the winner of its annual Technology Prize.
Tuesday, May 22, 2007
Labcyte Awarded 28th US Patent Describing Improved HTS Microplates
The US Patent 7,185, 969 describes microplates used in high-throughput screening that have low electrical resistance.
Thursday, March 15, 2007
Labcyte Awarded 27th U. S. Patent Describing Acoustic Transfer for the Preparation of Protein Microarrays
This broad patent expands the horizons for protein array preparation.
Thursday, August 17, 2006
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos